Patheon IncTSX: PTI

Patheon Announces Executive Management Changes

· Issued by Patheon Inc via CNW

TORONTO, Feb. 19 /CNW/ - Patheon Inc. (TSX: PTI) today announced changes in the roles of several of the Company's senior executives.

"This re-alignment of responsibilities will result in a more focused and effective executive team, enabling us to move forward to build and grow our business," said Mr. Wesley P. Wheeler, Chief Executive Officer, Patheon Inc.

Nick DiPietro will be assuming a new role as Executive Vice-President, Corporate Development and, accordingly, will relinquish his responsibilities as President and Chief Operating Officer of Patheon, effective March 1, 2008. In his new role, Mr. DiPietro will lead the development of a long-term corporate strategy and assist in evaluating future growth opportunities. He will continue to report to Wes Wheeler, Chief Executive Officer of Patheon Inc.

"I look forward to Nick's leadership and capitalizing on his creativity and entrepreneurial talent as we develop a new strategic plan for Patheon," said Mr. Wheeler.

Clive Bennett, currently President, Patheon U.S.A., will assume a new role as Chief Technical Officer, reporting to Wes Wheeler, CEO, effective March 1, 2008. In this newly created role, Mr. Bennett will be responsible for Patheon's global quality, supply chain, information technology and engineering functions. He also will continue to lead the Company in the divestiture of its Carolina Operations facility in Puerto Rico.

"With his extensive global experience, Clive is uniquely qualified for this role," said Mr. Wheeler. "I look forward to working with him to further harmonize Patheon's global operations and establish Patheon as the industry's best provider of pharmaceutical development and commercial manufacturing services."

Steve Liberty is appointed Senior Vice-President, Operations, Canada and U.S.A., and will assume responsibility for Patheon's Cincinnati and Burlington Century Laboratory facilities in addition to his current leadership of the Toronto Region, Whitby and York Mills sites. Mr. Liberty will report to Terence Novak, who joined Patheon on February 18, 2008 as President, North American Operations and Chief Marketing Officer.

Caution Concerning Forward-Looking Statements

This news release contains forward-looking statements which reflect management's expectations regarding the Company's future growth of operations, performance (both operational and financial) and business prospects and opportunities. These statements are made in the context of the risks and uncertainties that are outlined in the Company's public documents, which can be accessed on our website at www.patheon.com

Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. Patheon operates a network of 12 facilities in the United States, Canada and Europe, employing more than 4,650 people and serving a client base of more than 250 pharmaceutical and biotechnology companies.

%SEDAR: 00001700E

Patheon Inc on 6ix

Story so far

Earlier from Patheon

Later from Patheon

All Patheon news releases